Your browser doesn't support javascript.
loading
Genome-wide characterization of circulating metabolic biomarkers.
Karjalainen, Minna K; Karthikeyan, Savita; Oliver-Williams, Clare; Sliz, Eeva; Allara, Elias; Fung, Wing Tung; Surendran, Praveen; Zhang, Weihua; Jousilahti, Pekka; Kristiansson, Kati; Salomaa, Veikko; Goodwin, Matt; Hughes, David A; Boehnke, Michael; Fernandes Silva, Lilian; Yin, Xianyong; Mahajan, Anubha; Neville, Matt J; van Zuydam, Natalie R; de Mutsert, Renée; Li-Gao, Ruifang; Mook-Kanamori, Dennis O; Demirkan, Ayse; Liu, Jun; Noordam, Raymond; Trompet, Stella; Chen, Zhengming; Kartsonaki, Christiana; Li, Liming; Lin, Kuang; Hagenbeek, Fiona A; Hottenga, Jouke Jan; Pool, René; Ikram, M Arfan; van Meurs, Joyce; Haller, Toomas; Milaneschi, Yuri; Kähönen, Mika; Mishra, Pashupati P; Joshi, Peter K; Macdonald-Dunlop, Erin; Mangino, Massimo; Zierer, Jonas; Acar, Ilhan E; Hoyng, Carel B; Lechanteur, Yara T E; Franke, Lude; Kurilshikov, Alexander; Zhernakova, Alexandra; Beekman, Marian.
Afiliación
  • Karjalainen MK; Systems Epidemiology, Faculty of Medicine, University of Oulu and Biocenter Oulu, Oulu, Finland. minna.k.karjalainen@oulu.fi.
  • Karthikeyan S; Research Unit of Population Health, Faculty of Medicine, University of Oulu, Oulu, Finland. minna.k.karjalainen@oulu.fi.
  • Oliver-Williams C; Northern Finland Birth Cohorts, Arctic Biobank, Infrastructure for Population Studies, Faculty of Medicine, University of Oulu, Oulu, Finland. minna.k.karjalainen@oulu.fi.
  • Sliz E; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Allara E; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Fung WT; Public Health Specialty Training Programme, Cambridge, UK.
  • Surendran P; Systems Epidemiology, Faculty of Medicine, University of Oulu and Biocenter Oulu, Oulu, Finland.
  • Zhang W; Research Unit of Population Health, Faculty of Medicine, University of Oulu, Oulu, Finland.
  • Jousilahti P; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Kristiansson K; National Institute for Health and Care Research Blood and Transplant Research Unit in Donor Health and Behaviour, University of Cambridge, Cambridge, UK.
  • Salomaa V; Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK.
  • Goodwin M; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Hughes DA; Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK.
  • Boehnke M; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Fernandes Silva L; Rutherford Fund Fellow, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Yin X; British Heart Foundation Centre of Research Excellence, University of Cambridge, Cambridge, UK.
  • Mahajan A; Health Data Research UK Cambridge, Wellcome Genome Campus and University of Cambridge, Cambridge, UK.
  • Neville MJ; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
  • van Zuydam NR; Department of Cardiology, Ealing Hospital, London North West University Healthcare NHS Trust, London, UK.
  • de Mutsert R; Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland.
  • Li-Gao R; Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland.
  • Mook-Kanamori DO; Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland.
  • Demirkan A; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
  • Liu J; Population Health Science, Bristol Medical School, University of Bristol, Bristol, UK.
  • Noordam R; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
  • Trompet S; Population Health Science, Bristol Medical School, University of Bristol, Bristol, UK.
  • Chen Z; Department of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, MI, USA.
  • Kartsonaki C; Institute of Clinical Medicine, Internal Medicine, University of Eastern Finland, Kuopio, Finland.
  • Li L; Department of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, MI, USA.
  • Lin K; Department of Epidemiology, School of Public Health, Nanjing Medical University, Jiangsu, China.
  • Hagenbeek FA; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Hottenga JJ; Genentech, South San Francisco, CA, USA.
  • Pool R; NIHR Oxford Biomedical Research Centre, OUHFT Oxford, Oxford, UK.
  • Ikram MA; Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
  • van Meurs J; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Haller T; Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
  • Milaneschi Y; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
  • Kähönen M; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
  • Mishra PP; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
  • Joshi PK; Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands.
  • Macdonald-Dunlop E; Surrey Institute for People-Centred AI, University of Surrey, Guildford, UK.
  • Mangino M; Section of Statistical Multi-Omics, Department of Clinical and Experimental Medicine, University of Surrey, Guildford, UK.
  • Zierer J; Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Acar IE; Department of Epidemiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Hoyng CB; Department of Internal Medicine, Section of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, The Netherlands.
  • Lechanteur YTE; Department of Internal Medicine, Section of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, The Netherlands.
  • Franke L; Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.
  • Kurilshikov A; Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Zhernakova A; MRC Population Health Research Unit, University of Oxford, Oxford, UK.
  • Beekman M; Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Nature ; 628(8006): 130-138, 2024 Apr.
Article en En | MEDLINE | ID: mdl-38448586
ABSTRACT
Genome-wide association analyses using high-throughput metabolomics platforms have led to novel insights into the biology of human metabolism1-7. This detailed knowledge of the genetic determinants of systemic metabolism has been pivotal for uncovering how genetic pathways influence biological mechanisms and complex diseases8-11. Here we present a genome-wide association study for 233 circulating metabolic traits quantified by nuclear magnetic resonance spectroscopy in up to 136,016 participants from 33 cohorts. We identify more than 400 independent loci and assign probable causal genes at two-thirds of these using manual curation of plausible biological candidates. We highlight the importance of sample and participant characteristics that can have significant effects on genetic associations. We use detailed metabolic profiling of lipoprotein- and lipid-associated variants to better characterize how known lipid loci and novel loci affect lipoprotein metabolism at a granular level. We demonstrate the translational utility of comprehensively phenotyped molecular data, characterizing the metabolic associations of intrahepatic cholestasis of pregnancy. Finally, we observe substantial genetic pleiotropy for multiple metabolic pathways and illustrate the importance of careful instrument selection in Mendelian randomization analysis, revealing a putative causal relationship between acetone and hypertension. Our publicly available results provide a foundational resource for the community to examine the role of metabolism across diverse diseases.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Biomarcadores / Estudio de Asociación del Genoma Completo / Metabolómica Límite: Female / Humans / Pregnancy Idioma: En Revista: Nature Año: 2024 Tipo del documento: Article País de afiliación: Finlandia Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Biomarcadores / Estudio de Asociación del Genoma Completo / Metabolómica Límite: Female / Humans / Pregnancy Idioma: En Revista: Nature Año: 2024 Tipo del documento: Article País de afiliación: Finlandia Pais de publicación: Reino Unido